MIB1 proliferation index in breast infiltrating carcinoma: Comparison with other proliferative markers and association with new biological prognostic factors

Histology and Histopathology

Volumn 16, Issue 2, 2001, Pages 399-406

  Gonzalez Vela M C ^a   Garijo, M F ^a   Fernandez F ^a   Val Bernal, J F ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Breast carcinoma; Cathepsin D; MIB 1; Oncogene; Proliferation

Indexed keywords

BIOLOGICAL MARKER; CATHEPSIN D; ESTROGEN RECEPTOR; GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY KI 67; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; CANCER INFILTRATION; CANCER INVASION; CANCER SIZE; CELL CYCLE S PHASE; CELL PROLIFERATION; CORRELATION FUNCTION; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MITOSIS INDEX; ONCOGENE C ERB; PROGNOSIS; STATISTICAL ANALYSIS; STROMA CELL;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CATHEPSIN D; CELL DIVISION; DNA-BINDING PROTEINS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; MITOTIC INDEX; NUCLEAR PROTEINS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR, ERBB-2; S PHASE; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035073288     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cellular proliferation in breast ductal infiltrating carcinoma. Correlation with clinical and histopathological variables
2. The prognostic significance of DNA flow cytometry in breast cancer results from 881 patients treated in a single centre
3. Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB-1 and MIB-3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections
4. Prognostic impact of proliferation-associated factors MIB1 (Ki-67) and S-phase in node-negative breast cancer
5. DNA-flow cytometry and prognostic factors in 1331 frozen breast cancer specimens
6. Comparison of MIB-1 proliferation index with S-phase fraction in human breast carcinoma
7. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
8. The Nottingham prognostic index in primary breast cancer
9. Cell cycle analysis of a cell proliferation associated human nuclear definided by the monoclonal antibody Ki-67
10. Cathepsin D in host stromal cells is associated with more highly vascular and aggressive invasive breast carcinoma
11. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast
12. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody (PAP) procedures
13. Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer
14. MIB-1 labelling index is an independent prognostic marker in primary breast cancer
15. Stromal cell cathepsin D expression and long term survival in breast cancer
16. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating nuclear antigen, Ki-67 and MIB1
17. New Ki-67-equivalent murine monoclonal antibodies (MIB 1-3) generated against bacterially expressed parts of the Ki-67 cDNA containing three 62 base pair repetitive elements encoding for the Ki-67 epitope
18. Bcl-2 initiates a new category of oncogenes: Regulators of cell death
19. The p53 tumor suppressor gene
20. Clinical application of morphologic and immunocytochemical assessments of proliferation
21. Comparison of quantitative and semiquantitative methods of assessing MIB1 with the S-phase fraction in breast carcinoma
22. The origin and function of tumor-associated macrophages
23. Current concepts: Prognostic factors and treatment decisions in axillary-node-negative breast cancer
24. Proliferation marker MIB-1 correlates with proliferative activity evaluated by BrdU in breast cancer: An immunohistochemical study including correlation with PCNA, p53, c-erb B-2 and estrogen receptor status
25. Quantitative image analysis of MIB1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast
26. Assessment of the new proliferation marker MIB1 in breast carcinoma using image analysis: Associations with other prognostic factors and survival
27. MIB-1 proliferative activity in invasive breast cancer measured by image analysis
28. Ki-67 immunostaining in node negative stage I-II breast cancer
29. Biological and clinicopathological factors as indicators of specific relapse types in node-negative breast cancer
30. Expression of mitoses per thousand cells and cell density in breast carcinomas: A proposal
31. S-phase fraction is a prognostic factor in stage I breast carcinoma
32. Immunohistochemical detection of bcl-2 and MIB1/Ki67 in breast cancer: Retrospective analysis of 238 cases
33. Reproducibility of mitosis counting in 2,469 breast cancer specimens. Results from the multicenter morphometric mammary carcinoma project
34. Proliferation index as a prognostic marker in breast cancer
35. Autocrine growth stimulation of MCF 7 breast cancer cells by estrogen-regulated 52 K protein
36. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis
37. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel paraffin reactive MIB1 antibody
38. Measuring cell proliferation
39. Expression of c-erbB-2 oncoprotein: A prognostic indicator in human breast cancer